ABSTRACT Introduction Hepatitis C virus (HCV) infection is associated with an increased
incidence and progression of chronic kidney disease (CKD), as well as higher mortality in …

The management of HCV infection in kidney transplantation presents significant challenges.
HCV, left untreated, worsens patient and graft survival after kidney transplantation through …

Hepatitis C virus (HCV) has emerged as a major global health concern and, if left untreated,
can lead to significant liver damage, including cirrhosis, decompensated liver disease, and …

Chronic hepatitis C virus (HCV) infection is a major global public health problem, particularly
in developing part of the world. Significant advances have been made in the early diagnosis …

Background Cognitive impairment in patients with hepatitis C virus (HCV) is reported in the
early onset of HCV infection without hepatic cirrhosis or marked liver impairment. Methods …

Aim: In Switzerland, the first access to interferon-free direct-acting antivirals (DAAs) for
hepatitis C virus (HCV) treatment was in 2014. This study aimed to analyze the effects of …

The paradigm shift from interferon-based to direct-acting antiviral (DAA) therapy for the
treatment of hepatitis C virus (HCV) infection has revolutionized the field of liver …

Introduction. Hepatitis C virus (HCV) infection continues to represent a poor prognostic factor
in kidney transplant (KTx) patients. New direct‐acting antiviral agents (DAA) have …

Abstract Hepatitis C Virus (HCV) could be a risk factor for neuropsychiatric illness and a
predisposing factor for meningoencephalitis caused by opportunistic organisms such as …